EDGAR Filing Documents for 0001279569-11-001282

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001279569-11-001282

Filing Date

2011-11-14

Accepted

2011-11-14 11:17:02

Documents

Period of Report

2011-08-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 6-K	lorus6k.htm	6-K	16207
2	Q1 INTERIM FINANCIAL STATEMENTS	ex991.htm	EX-99.1	893180
3	Q1 MANAGEMENTS DISCUSSION AND ANALYSIS	ex992.htm	EX-99.2	458311
4	CEO/CFO CERTIFICATES	ex993.htm	EX-99.3	36472
	Complete submission text file	0001279569-11-001282.txt		1405392

Mailing Address 2 MERIDIAN ROAD TORONTO A6 M9W 4Z7

Business Address 2 MERIDIAN ROAD . TORONTO A6 M9W 4Z7

LORUS THERAPEUTICS INC (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0531
Type: 6-K | Act: 34 | File No.: 001-32001 | Film No.: 111199193
SIC: 2836 Biological Products, (No Diagnostic Substances)